Trastuzumab in Early-Stage Breast Cancer Steven Simoens Commentary 17 September 2012 Pages: 807 - 809
Funding a Clinical Trial Peter AlsopScott MetcalfeJackie Evans Commentary 17 September 2012 Pages: 811 - 814
Unrelated Medical Costs in Life-Years Gained David R. RappangePieter H. M. van BaalWerner B. F. Brouwer Current Opinion 17 September 2012 Pages: 815 - 830
Quality-of-Life Assessment in Rheumatoid Arthritis Anthony S. Russell Review Article 17 September 2012 Pages: 831 - 846
Multiple Sclerosis in the UK Paul McCroneMargaret HeslinAlan Thompson Original Research Article 17 September 2012 Pages: 847 - 860
Costs and Effects of Secondary Prevention with Perindopril in Stable Coronary Heart Disease in Poland W. Ken RedekopEwa OrlewskaLouis W. Niessen Original Research Article 17 September 2012 Pages: 861 - 877
Long-Term Cost-Effectiveness Analysis of Nebivolol Compared with Standard Care in Elderly Patients with Heart Failure Guiqing YaoNick FreemantlePhilip A. Poole-Wilson Original Research Article 17 September 2012 Pages: 879 - 889
Assessing the Value of a Future Study Afschin Gandjour Correspondence 17 September 2012 Pages: 891 - 892
The Authors’ Reply Oren ShavitMoshe LeshnoAmnon Hoffman Correspondence 17 September 2012 Pages: 892 - 894
